G. Ojeda

P. Portolés, J. Rojo, M. Feito, 1994, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes.

J. Rojo, A. Portolés, M. Portolés, 1985, Immunopharmacology.

PI3-Kinase p110α Deficiency Modulates T Cell Homeostasis and Function and Attenuates Experimental Allergic Encephalitis in Mature Mice

U. Dianzani, P. Portolés, J. Rojo, 2021, International journal of molecular sciences.

The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis

P. Portolés, G. Criado, J. Rojo, 2021, International journal of molecular sciences.

Genetic and immunochemical evidence for CD4‐dependent association of p56lck with the alpha beta T‐cell receptor (TCR): regulation of TCR‐induced activation.

P. Portolés, G. Criado, J. Rojo, 1994, The EMBO journal.

In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.

I. Barasoain, J. Rojo, M. Rejas, 1986, International journal of immunopharmacology.

Suppression of immune parameters in animal models of morphine dependence.

J. Portolés, J. Rojo, J. Leza, 1995, Immunological investigations.

Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.

I. Barasoain, J. Rojo, M. Rejas, 1987, International journal of immunopharmacology.

T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response

U. Dianzani, P. Portolés, J. Rojo, 2018, Front. Immunol..

Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.

I. Barasoain, J. Rojo, A. Portolés, 1983, Journal of immunopharmacology.

Enhancement and restoration of contact sensitivity reactions by isoprinosine.

J. Rojo, M. Portolés, G. Ojeda, 1983, Journal of immunopharmacology.

ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.

J. Herranz, U. Dianzani, C. Blanco-Aparicio, 2016, Biochemical pharmacology.

ICOS deficiency hampers the homeostasis, development and function of NK cells

U. Dianzani, P. Portolés, J. Rojo, 2019, PloS one.

Characteristics of TCR/CD3 complex CD3ɛ chains of regulatory CD4+ T (Treg) lymphocytes: role in Treg differentiation in vitro and impact on Treg in vivo

P. Portolés, G. Criado, J. Rojo, 2014, Journal of leukocyte biology.

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

E. López-Granados, V. Pothula, E. Guccione, 2021, Cell Reports.

The renaissance of T regulatory cells: Looking for markers in a haystack

P. Portolés, Eliana Pini, G. Ojeda, 2007 .

Enhancement of lymphocyte proliferation, interleukin-2 production and NK activity by inmunoferon (AM-3), a fungal immunomodulator: variations in normal and immunosuppressed mice.

I. Barasoain, P. Portolés, J. Rojo, 1986, International journal of immunopharmacology.

Inhibition of T and B lymphoblastic response by mithramycin, dacarbazine, prospidium chloride and peptichemio.

J. Rojo, A. Portolés, M. Portolés, 1983, Chemotherapy.

A hyperreactive variant of a CD4+ T cell line is activated by syngeneic antigen presenting cells in the absence of antigen.

P. Portolés, J. Rojo, M. Feito, 1995, Cellular immunology.

Properties on Mouse T Cells Regulatory Protein, Has Costimulatory Crry/p65, a Membrane Complement

P. Portolés, E. Fernández-Centeno, J. Rojo, 2017 .

Variability of invariant mouse CD3ϵ chains detected by anti‐CD3 antibodies

C. Janeway, P. Portolés, G. Criado, 2000 .